We are monitoring the impact of COVID-19 & Recession alarm on APAC Cardiovascular Therapeutic Drugs Market Get in touch with us for detailed analysis Know More
Share on

Asia-Pacific Cardiovascular Therapeutic Drugs Market Research Report – Segmented By Disease, Drug Class & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecast (2022 to 2027)

Published: January, 2022
ID: 1353
Pages: 145

The size of the Asia-Pacific Cardiovascular Therapeutic Drugs is a USD 28.53 billion market in 2022 and is projected to reach USD 32.44 billion by 2027, growing with a cumulative annual growth rate (CAGR) of 2.6%. Several new and effective drug therapies for cardiovascular disorders have been development in the past few decades. With the rising prevalence of cardiovascular diseases, the market for therapeutics drugs is likely to grow in the future.

Cardiovascular drugs include medicines or drugs that are administered for the diseases that are related to the function and structure of blood vessels and heart. While cardiovascular disorders continue to be leading cause of death globally, the major disorders include heart failure, high cholesterol, coronary artery disease and blood clots among others.

Cardiovascular diseases remain the common cause of mortality and morbidity across the globe and is an emerging threat. The driving factors for the cardiovascular therapeutics includes growing per capita medical spending, rising aging population and epidemic of general medical problems which includes obesity and diabetes. However, there are few restraints faced by the market which includes high costs involving drug development and lowering of target population. Cardiovascular diseases remain the common cause of mortality and morbidity across the globe and is an emerging threat. Despite its extensive existence, many of the drug development pipelines has been stagnant for variety of factors.

Asia-Pacific market for cardiovascular therapeutic drugs market is segmented into diseases and drug class. Based on the type of cardiovascular diseases, the market is studied as hypertension, thrombosis, hyperlipidaemia, Arteriosclerosis, Coronary artery disease, Peripheral artery disease, Cardiac arrhythmias, acute coronary syndrome, Myocardial infarction, cardiac failure diseases and other diseases. Asia-Pacific market based on its geographical regions, is segmented into China, Japan, India, South Korea and Australia.

Some of the major companies leading in the industry includes Bayer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Novartis, Merck, Takeda, Sanofi, Pfizer and boehringer ingelheim.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Disease                  

                                5.1.1 Arteriosclerosis     

                                5.1.2 Cardiac arrhythmias            

                                5.1.3 Myocardial infarction         

                                5.1.4 Acute Coronary Syndrome

                                5.1.5 Peripheral artery disease  

                                5.1.6 Coronary artery disease    

                                5.1.7 Hypertension        

                                5.1.8 Hyperlipidaemia   

                                5.1.9 Thrombosis            

                                5.1.10 Cardiac failure diseases  

                                5.1.11 Others   

                5.2 By Drug Class                             

                                5.2.1 Monotherapies     

                                5.2.2 Combination Therapies     

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7. Pipeline Product Analysis                                        

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                     

                7.3 Molecular Targets in the Pipeline                                     

                7.4 Clinical Trials                              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.               

8. Strategic Analysis                                       

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental      

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry      

9. Market Leaders' Analysis                                        

                9.1 AstraZeneca               

                                9.1.1 Overview

                                9.1.2 Product Analysis   

                                9.1.3 Strategic Evaluation and Operations            

                                9.1.4 Financial analysis  

                                9.1.5 Legal issues            

                                9.1.6 Recent Developments       

                                9.1.7 SWOT analysis       

                                9.1.8 Analyst View          

                9.2 Novartis                       

                9.3 Bristol-Myers Squibb                              

                9.4 Pfizer                            

                9.5 Sanofi                           

                9.6 Merck                           

                9.7 Bayer                            

                9.8 Takeda                         

                9.9 Boehringer Ingelheim                            

                9.10 Johnson & Johnson                              

10. Competitive Landscape                                         

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                       

                10.4 New Product Launches                       

11. Expert Opinions                                        

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Cardiovascular Therapeutic Drugs Market, By Region, From 2022 - 2027 (USD Billion)
  2. Asia-Pacific Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)
  3. Asia-Pacific Arteriosclerosis Market, By Region, From 2022 - 2027 (USD Billion)    
  4. Asia-Pacific Cardiac arrhythmias Market, By Region, From 2022 - 2027 (USD Billion)           
  5. Asia-Pacific Myocardial infarction Market, By Region, From 2022 - 2027 (USD Billion)         
  6. Asia-Pacific Acute Coronary Syndrome Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia-Pacific Peripheral artery disease Market, By Region, From 2022 - 2027 (USD Billion)  
  8. Asia-Pacific Coronary artery disease Market, By Region, From 2022 - 2027 (USD Billion)    
  9. Asia-Pacific Hypertension Market, By Region, From 2022 - 2027 (USD Billion)        
  10. Asia-Pacific Hyperlipidaemia Market, By Region, From 2022 - 2027 (USD Billion)   
  11. Asia-Pacific Thrombosis Market, By Region, From 2022 - 2027 (USD Billion)            
  12. Asia-Pacific Cardiac failure diseases Market, By Region, From 2022 - 2027 (USD Billion)     
  13. Asia-Pacific Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)          
  14. Asia-Pacific Monotherapies Market, By Region, From 2022 - 2027 (USD Billion)     
  15. Asia-Pacific Combination Therapies Market, By Region, From 2022 - 2027 (USD Billion)     
  16. China Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)          
  17. China Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)     
  18. India Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)            
  19. India Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)      
  20. Japan Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)          
  21. Japan Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)     
  22. South Korea Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)             
  23. South Korea Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)        
  24. Australia Cardiovascular Therapeutic Drugs Market, By Disease, From 2022 - 2027 (USD Billion)    
  25. Australia Cardiovascular Therapeutic Drugs Market, By Drug Class, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample